MARKET

VTRS

VTRS

Viatris Inc Ord Shs
NASDAQ
16.51
+0.13
+0.79%
After Hours: 16.45 -0.06 -0.36% 19:30 09/11 EDT
OPEN
16.50
PREV CLOSE
16.38
HIGH
16.65
LOW
16.32
VOLUME
12.17M
TURNOVER
--
52 WEEK HIGH
18.25
52 WEEK LOW
9.10
MARKET CAP
18.96B
P/E (TTM)
-46.2335
1D
5D
1M
3M
1Y
5Y
1D
Viatris: Strong Cash Generation And Pipeline Progress Keep The Re-Rating Story Alive
Seeking Alpha · 4d ago
Viatris Price Target Announced at $20.00/Share by Leerink Partners
Dow Jones · 4d ago
Viatris Initiated at Outperform by Leerink Partners
Dow Jones · 4d ago
Leerink Partners Initiates Coverage On Viatris with Outperform Rating, Announces Price Target of $20
Benzinga · 4d ago
Leerink sees growth for Viatris, starts at Outperform
TipRanks · 4d ago
Viatris price target raised to $20 from $15 at Argus
TipRanks · 5d ago
Weekly Report: what happened at VTRS last week (0831-0904)?
Weekly Report · 6d ago
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks
Seeking Alpha · 09/05 15:05
More
About VTRS
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.

Webull offers Viatris Inc stock information, including NASDAQ: VTRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VTRS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VTRS stock methods without spending real money on the virtual paper trading platform.